NCT05562856

Brief Summary

Dental caries is the primary cause of tooth loss and oral diseases. Dental decay is a continuous pathological process with loss of tooth minerals, demineralization, which involves the destruction of tooth structure from acids. The first sign of early active demineralization is white spot lesions (WSLs) on the tooth surface, meanwhile, subsurface active mineral decomposition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 20, 2020

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 2, 2021

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 3, 2021

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

September 16, 2022

Completed
17 days until next milestone

First Posted

Study publicly available on registry

October 3, 2022

Completed
Last Updated

October 4, 2022

Status Verified

September 1, 2022

Enrollment Period

1.9 years

First QC Date

September 16, 2022

Last Update Submit

September 30, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Assessments of caries lesion state of WSLs:

    Assessing of carious lesions state of WSLs, was performed by using Diagnodent pen to record the progression or regression of caries by time. The assessment of the WSLs demineralization condition took place before intervention (baseline) \[T0\], immediately after intervention \[T1\], 3 months later \[T2\] ,6 months later \[T3\] and 1 year later \[T4\].

    1 year

Secondary Outcomes (1)

  • Assessment of color change of WSLs:

    1 year

Study Arms (4)

surface pre-reacted glass filler coating material

EXPERIMENTAL

surface pre-reacted glass filler coating material used to remineralize WSLs

Combination Product: surface pre-reacted glass filler coating material

micro-invasive resin infiltration technique (Icon)

ACTIVE COMPARATOR

micro-invasive resin infiltration technique (Icon) in the ability to improve caries lesion state (LF scores) and making the WSLs

Combination Product: surface pre-reacted glass filler coating material

Permaseal resin

EXPERIMENTAL

Permaseal composite resin sealant as micro-invasive resin infiltration technique in the ability to improve caries lesion state (LF scores) and making the WSLs

Combination Product: surface pre-reacted glass filler coating material

Optiguard resin

EXPERIMENTAL

Optiguardcomposite resin sealant as micro-invasive resin infiltration technique in the ability to improve caries lesion state (LF scores) and making the WSLs

Combination Product: surface pre-reacted glass filler coating material

Interventions

the ability to improve the aesthetic appearance (masking) and caries lesion state of the WSLs

Optiguard resinPermaseal resinmicro-invasive resin infiltration technique (Icon)surface pre-reacted glass filler coating material

Eligibility Criteria

Age20 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients within 20-40 years of age.
  • Each patient has 4 or more WSLs.
  • Mild and moderate WSLs according to Gorelick's scale.
  • Good oral hygiene and willing patients who can attend the study visits.
  • a Symmetrical number of permanent teeth in each arch (mesial to second molars).

You may not qualify if:

  • Active carious lesions.
  • Facial surface restorations.
  • Intrinsic and extrinsic stains.
  • Patients who have a significant medical history or if they smoke.
  • Criteria for discontinuation; Mortality and acquiring severe debilitating disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mohamed Wakwak

Cairo, 11768, Egypt

Location

Study Officials

  • Khalid Noman, PROF

    Alazhar Univerisity

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

September 16, 2022

First Posted

October 3, 2022

Study Start

January 20, 2020

Primary Completion

December 2, 2021

Study Completion

December 3, 2021

Last Updated

October 4, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations